Under ESOS
Glenmark Pharmaceuticals announced that the Operations Committee of the Board of Directors of the Company, at its Meeting held on 22 August 2014 allotted 14,750 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.Powered by Capital Market - Live News
